Antimalarial agents

Antimalarial agents, Medicinal chemistry, Research

The spread of drug-resistant malaria parasites urges the search for new antimalarial drugs. Malarial aspartic proteases – plasmepsins (Plms) – are attractive drug targets. In collaboration with the group of Prof. A. Jirgensons (Institute of Organic Synthesis), we are involved in the development of Plm inhibitors as antimalarial drugs.


ERAF grants No. 2DP/ and No.

ERAF grants No. 2DP/ and No.